WASHINGTON – The labels on two prescription creams to treat eczema will have to bear “black box” warnings of possible cancer risks. The Food and Drug Administration action on Thursday follows an agency advisory committee recommendation last February that Elidel cream and Protopic ointment carry… Read More
Comments for: FDA requires warnings on two eczema drugs
FDA requires warnings on two eczema drugs
You may also like
FDA requires warnings on two eczema drugs